The Supreme Court said the pharma marketing code must be strong enough to let cheated consumers file easy complaints and get proper remedies. The Bench questioned why the government’s UCPMP 2024 still lacks a solid, enforceable complaint mechanism.
The Supreme Court of India overturned a prison term for a doctor found with unlicensed drugs, instead imposing a Rs 1 lakh fine. The ruling emphasizes that possessing a small quantity of medicines without disclosing the source does not endanger public interest, particularly when intent to sell or distribute remains unproven. This significant judgment provides legal protection for healthcare professionals stocking medicines for patient care.
